Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicineMohamed R. Akl(University of Louisiana at Monroe), K. Stephen Suh(Hackensack University Medical Center)OncotargetJuly 22, 201510.18632/oncotarget.4981Cited by 97SaveCiteExport RISWatch citationsRelated PapersOlive Phenolics as c-Met Inhibitors: (-)-Oleocanthal Attenuates Cell Proliferation, Invasiveness, and Tumor Growth in Breast Cancer Models|PLoS ONE|2014|126